2027 Innovation Suite
AI-powered personalization tools combining community leadership with advanced AI for patient-HCP connections
Company profile
Company profile
Health Union operates condition-specific online communities and uses AI to connect patients with relevant health information, peer support, and clinical trial opportunities.
Company description Health Union official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Launched 2027 Innovation Suite with AI personalization tools (June 2026), expanded portfolio with new communities in Oncology and Rare Diseases (February 2026), launched Social Health Awards (2026), partnership with Institute for Responsible Influence for patient advocacy standards (April 2026)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered personalization tools combining community leadership with advanced AI for patient-HCP connections
Coordinated brand advertising across patient and HCP communities using shared behavioral signals
Patient-centric approach throughout clinical trial design, recruitment, and patient experience
Industry's first and largest community-based activation and data platform for health engagement
Reach highly engaged patients through influencers, audience activations, and content sponsorships
Access the largest first-party HCP data set for omnichannel programmatic activation
Tech-enabled research tools delivering qualitative and quantitative health journey intelligence
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Clinical oncology (Royal College of Radiologists (Great Britain)) · Sep 1, 2026
Clinical Manifestations, Diagnosis, and Therapeutic Advances in May-Thurner Syndrome: A Comprehensive Literature Review.Current problems in cardiology · Jul 19, 2026
Heated nebulization of ambroxol hydrochloride: engineering submicron aerosols for pulmonary drug delivery.International journal of pharmaceutics · Jun 20, 2026
Hydrocortisone Dosing Frequency in Intensive Care Unit Patients With Septic Shock: A Comparison of 2 Regimens.The Annals of pharmacotherapy · Mar 1, 2026
Potential Benefit of Inferior Turbinate Reduction With Adenotonsillectomy for Obstructive Sleep Apnea.JAMA otolaryngology-- head & neck surgery · Nov 1, 2025
Graft remodelling of hamstring ACL graft and secondary meniscal lesions are affected by tibial slope and body mass index.Journal of experimental orthopaedics · Oct 1, 2025
Clinical validation
NCT05624996 · Mentioned · RECRUITING
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialNCT04513717 · Mentioned · ACTIVE NOT RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseaseNCT05174169 · Mentioned · RECRUITING
ETIC (Therapeutic Education in Heart Failure)NCT01065142 · Sponsor · ACTIVE NOT RECRUITING
Clinical Study on ShouTai Pills for Improving Reduced Ovarian ReserveNCT07737847 · Sponsor · NOT YET RECRUITING
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerNCT01810913 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
First-party data platform
HCP community engagement
Largest unique first-party HCP dataset
Community and programmatic activation
Contributing community members
Patient-authored articles
Engaging patients and HCPs through community-based activation and data platform
95% of the Top 20 Pharma Manufacturers are Partners
05 · Leadership
Leadership profiles and professional links from the current Company record.
Erin Poyant
Content Writer | Health Leader
Jenny J.
Rare Disease Patient Leader Influencer
Porscha Simmons
Writer/Health Advocate
Ainaa Farhanah
Advocate
Joey Fontana
Vice President, Business Development
Danielle Alstat
Patient Leader
Katie MacTurk
Vice President, Insights
Courtney Nolan Robertson
Vice President, Insights
06 · Company updates
Recent articles published on Health Union's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to engage patients, provide health education, facilitate peer support, offer AI health coaching, or help patients navigate their healthcare journey. Includes patient communities, AI health mentors, peer support networks, and platforms that empower patients to take an active role in managing their own health.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.